The trademark application CANCER VISION was filed by Inocras Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 5, 2022, and it was registered by office on October 12, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on September 16, 2024.
Goods And Services
The mark was filed in class 9 with following description of goods:
Genetic information provision software
Genetic sequence information processing software
Genetic information navigating software
Genetic information analyzing software
Genetic information interpretation software
DNA analysis apparatus
DNA sequencing devices
Genetic sequence information processing device
Genetic information navigating device
Genetic information analyzing device
Genetic information interpretation device
Computer software for diagnosing cancer for medical purposes
Computer software for diagnosing diseases for medical purposes
Computer software for use in medical decision support systems.